Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
789411
Reference Type
Journal Article
Title
Simultaneous determination of amantadine and rimantadine by HPLC in rat plasma with pre-column derivatization and fluorescence detection for pharmacokinetic studies
Author(s)
Higashi, Y; Uemori, I; Fujii, Y
Year
2005
Is Peer Reviewed?
Yes
Journal
Biomedical Chromatography
ISSN:
0269-3879
EISSN:
1099-0801
Volume
19
Issue
9
Page Numbers
655-662
Language
English
PMID
15803448
DOI
10.1002/bmc.492
Abstract
We investigated simultaneous high-performance liquid chromatographic (HPLC) determination of amantadine hydrochloride (AMA) and rimantadine hydrochloride (RIM) levels in rat plasma after fluorescent derivatization with o-phthalaldehyde and 2-mercaptoethanol. Afterwards, the method was applied to determine their pharmacokinetics. The retention times of AMA and RIM derivatives were 12.6 and 22.2 min and the lower limits of detection were 0.025 and 0.016 microg/mL, respectively. The coefficients of variation for intra- and inter-day assay of AMA and RIM were less than 5.1 and 7.6%, respectively. After i.v. administration of AMA or RIM to rats, the total body clearance and distribution volume at the steady-state of RIM were higher than those of AMA. Bioavailability of AMA and RIM was 34.9 and 37.2%, respectively. When AMA and RIM were p.o. co-administered, the area under the plasma concentration--time curve of RIM was significantly lower than that after RIM alone. On the other hand, pharmacokinetic parameters of AMA did not significantly change. These results indicate that our HPLC assay is simple, rapid, sensitive and reproducible for simultaneously determining AMA and RIM concentrations in rat plasma and is applicable to their pharmacokinetic studies. Also, co-administration of AMA and RIM may result in the lack of pharmacological effects of RIM.
Keywords
Amantadine/analogs & derivatives/ blood/pharmacokinetics; Animals; Chromatography, High Pressure Liquid/ methods; Fluorescent Dyes/chemistry; Kinetics; Male; Mercaptoethanol/chemistry; Rats; Rats, Wistar; Reproducibility of Results; Rimantadine/analogs & derivatives/ blood/pharmacokinetics; o-Phthalaldehyde/chemistry
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity